Anebulo Pharmaceuticals (ANEB) Return on Equity [ROE] (2021 - 2025)
Anebulo Pharmaceuticals (ANEB) recorded Return on Equity [ROE] of -101.84% in fiscal Q2 2026 (quarter ended Dec 31, 2025), down 4.31 percentage points from -97.52% a year earlier and down 16.51 percentage points from the prior quarter.
Powered by 
Analysis
Anebulo Pharmaceuticals (ANEB) Return on Equity [ROE] (2021 - 2025) Analysis & Trends
For FY2025 (ended Jun 30, 2025), Anebulo Pharmaceuticals reported Return on Equity [ROE] of -121.08%, down 6.47 percentage points from FY2024.
- Annual Return on Equity [ROE] has declined for four straight fiscal years, with a four-year change of -87.05 percentage points (FY2021 to FY2025).
- Across earlier fiscal years, Return on Equity [ROE] came in at -114.61% in FY2024 (-23.51 pp), -91.09% in FY2023 (-53.68 pp), -37.41% in FY2022 (-3.39 pp) and -34.03% in FY2021.
- The fiscal Q2 2026 figure is the lowest quarterly Return on Equity [ROE] since fiscal Q1 2025.
- On a year-over-year basis, Return on Equity [ROE] rose in four of the last eight quarters, with an average year-over-year change of +15.15 percentage points.
- Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 203.83 percentage points in fiscal Q1 2026, against a drop of 166.92 percentage points in fiscal Q1 2025 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at -85.33% (Q1 2026), -75.21% (Q4 2025) and -60.52% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | Anebulo Pharmaceuticals | 13.15 Mn | 13.15 Mn | - | -101.84% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -101.84% |
| Sep 30, 2025 | -85.33% |
| Jun 30, 2025 | -75.21% |
| Mar 31, 2025 | -60.52% |
| Dec 31, 2024 | -97.52% |
| Sep 30, 2024 | -289.16% |
| Jun 30, 2024 | -187.77% |
| Mar 31, 2024 | -163.09% |
| Dec 31, 2023 | -141.51% |
| Sep 30, 2023 | -122.24% |
| Jun 30, 2023 | -99.36% |
| Mar 31, 2023 | -81.01% |
| Dec 31, 2022 | -61.34% |
| Sep 30, 2022 | -46.15% |
| Jun 30, 2022 | -42.39% |
| Mar 31, 2022 | -38.69% |
| Dec 31, 2021 | -29.14% |
| Sep 30, 2021 | -23.77% |
| Jun 30, 2021 | -60.22% |
API Access
Anebulo Pharmaceuticals Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ANEB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "ANEB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ANEB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();